To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Robert Simon JohnsonRobert JohnsonIn early 2007 Robert Johnson became the first person in the world to undergo gene therapy treatment on the eye. Born with an inherited retinal dystrophy Robert was operated on by a team at world renowned Moorfields Eye Hospital in London, led by Mr James Bainbridge, as part of a gene therapy clinical trial headed by Professor Robin Ali of University College London's Institute of Ophthalmology. Additional recommended knowledgeAlthough results are unlikely to be published for some time, the medical team hope that the insertion of a correct copy of the RPE65 gene will allow patients to recover, or in the very least, retain a degree of sight. In The Media
|
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Robert_Simon_Johnson". A list of authors is available in Wikipedia. |